高级检索
当前位置: 首页 > 详情页

The potential of large language models to advance precision oncology

文献详情

资源类型:
Pubmed体系:
机构: [1]Department of Pulmonary and Critical Care Medicine, State Key Laboratory of Respiratory Health and Multimorbidity, Targeted Tracer Research and Development Laboratory, Frontiers Science Center for Disease-Related Molecular Network, West China Hospital, West China School of Medicine, Sichuan University, Chengdu, China. [2]State Key Laboratory of Networking and Switching Technology, Beijing University of Posts and Telecommunications, Beijing, China. [3]UCL Cancer Institute, University College London, London WC1E 6BT, UK. [4]Frontiers Medical Center, Tianfu Jincheng Laboratory, Chengdu, China.
出处:

关键词: Oncology Large language model Artificial intelligence Diagnosis Treatment

摘要:
With the rapid development of artificial intelligence (AI) within medicine, the emergence of large language models (LLMs) has gradually reached the forefront of clinical research. In oncology, by mining the underlying connection between a text or image input and the desired output, LLMs demonstrate great potential for managing tumours. In this review, we provide a brief description of the development of LLMs, followed by model construction strategies and general medical functions. We then elaborate on the role of LLMs in cancer screening and diagnosis, metastasis identification, tumour staging, treatment recommendation, and documentation processing tasks by decoding various types of clinical data. Moreover, the current barriers faced by LLMs, such as hallucinations, ethical problems, limited application, and so on, are outlined along with corresponding solutions, where the further purpose is to inspire improvement and innovation in this field with respect to harnessing LLMs for advancing precision oncology.Copyright © 2025 The Author(s). Published by Elsevier B.V. All rights reserved.

基金:
语种:
PubmedID:
中科院(CAS)分区:
出版当年[2025]版:
大类 | 1 区 医学
小类 | 1 区 医学:研究与实验
最新[2025]版:
大类 | 1 区 医学
小类 | 1 区 医学:研究与实验
第一作者:
第一作者机构: [1]Department of Pulmonary and Critical Care Medicine, State Key Laboratory of Respiratory Health and Multimorbidity, Targeted Tracer Research and Development Laboratory, Frontiers Science Center for Disease-Related Molecular Network, West China Hospital, West China School of Medicine, Sichuan University, Chengdu, China.
共同第一作者:
通讯作者:
通讯机构: [1]Department of Pulmonary and Critical Care Medicine, State Key Laboratory of Respiratory Health and Multimorbidity, Targeted Tracer Research and Development Laboratory, Frontiers Science Center for Disease-Related Molecular Network, West China Hospital, West China School of Medicine, Sichuan University, Chengdu, China. [4]Frontiers Medical Center, Tianfu Jincheng Laboratory, Chengdu, China.
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:59688 今日访问量:0 总访问量:4873 更新日期:2025-07-01 建议使用谷歌、火狐浏览器 常见问题

版权所有©2020 四川省肿瘤医院 技术支持:重庆聚合科技有限公司 地址:成都市人民南路四段55号